Kim Janda

Insider Reports History

Location
San Diego, CA
Signature
/s/ Henry Ji, Ph.D., as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kim Janda:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sorrento Therapeutics, Inc. Director Common Stock 3K $2.41K $0.80 27 Dec 2021 Direct
Sorrento Therapeutics, Inc. Director Stock Options 27.6K 27 Sep 2021 Direct
Sorrento Therapeutics, Inc. Director Non-qualified stock option 0 27 Dec 2021 Direct

Insider Reports Filed by Kim Janda

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SRNEQ Sorrento Therapeutics, Inc. 31 Dec 2021 1 -$31.3K 5 Director 06 Feb 2023, 20:10
SRNEQ Sorrento Therapeutics, Inc. 27 Dec 2021 3 -$5.64K 4 Director 27 Dec 2021, 18:34
SRNEQ Sorrento Therapeutics, Inc. 27 Sep 2021 5 -$250K 4 Director 28 Sep 2021, 17:37
SRNEQ Sorrento Therapeutics, Inc. 13 Sep 2021 3 -$36.3K 4 Director 14 Sep 2021, 17:00
SRNEQ Sorrento Therapeutics, Inc. 30 Aug 2021 1 $0 4 Director 30 Aug 2021, 20:13